ReviewCancers2021

Genetic Heterogeneity, Therapeutic Hurdle Confronting Sorafenib and Immune Checkpoint Inhibitors in Hepatocellular Carcinoma.

Sara M Atwa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.